A panel of eight neutralizing monoclonal antibodies (MAbs) against the fusion (F) protein of Newcastle disease virus (NDV) has been shown to locate a major antigenic site on the basis of competitive binding assay and additivity index studies. Five epitopes (A1 to A5) have been located within this site on the F protein of the Beaudette C strain of NDV on the basis of cross-resistance plaque assays of MAb-resistant mutants raised against these MAbs. Epitopes A1, A4 and A5 are distinct; epitope A2 partially overlaps epitope A3. Nucleotide sequence analysis of the F genes of MAb-resistant mutants showed that each predicted single amino acid substitutions ranging from amino acid residues 157 to 171 for epitope A4 and at residues 72, 78, 79 and 343 for epitopes A1, A2, A3 and A5 respectively. These locations indicate that both the F1 and F2 fragments are involved in the formation of a single antigenic site and suggest the involvement of extensive protein folding in the active form of this F protein.
ChambersP.,
MillarN. S.,
EmmersonP. T.1986; Nucleotide sequence of the gene encoding the fusion glycoprotein of Newcastle disease virus. Journal of General Virology 67:2685–2694
GethingM. J.,
WhiteJ. M.,
WaterfieldM. D.1978; Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proceedings of the National Academy of SciencesU.S.A752737–2740
HullJ. D.,
KrahD. L.,
ChoppinP. W.1987; Resistance of a measles virus mutant to fusion inhibitory oligopeptides is not associated with mutations in the fusion peptide. Virology 159:368–372
Le long,
PortetelleD.,
GhysdaelJ.,
GonzeM.,
BurnyA.,
MeulemansG.1986; Monoclonal antibodies to hemagglutinin-neuraminidase and fusion glycoproteins of Newcastle disease virus: relationship between glycosylation and reactivity. Journal of Virology 57:1198–1202
McGinnesL. W.,
SemerjianA.,
MorrisonT. G.1985; Conformational changes in Newcastle disease virus fusion glycoprotein during intracellular transport. Journal of Virology 56:341–348
MerzD.,
ScheidA.,
ChoppinP. W.1981; Importance of antibodies to the fusion glycoproteins in the prevention of spread of infection. Journal of Experimental Medicine 151:275–288
NeytC,
GeliebterJ.,
SlaouiM.,
MoralesD.,
MeulemansG.,
BurnyA.1989; Mutations located on both Fi and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies. Journal of Virology 63:952–954
NishikawaK.,
IsomuraS.,
SuzukiS.,
WatanabeE.,
HamaguchiM.,
YoshidaT.,
NagaiY.1983; Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons. Virology 130:318–330
PortnerA.,
ScroggsR. A.,
NaeveC. W.1987; The fusion glycoprotein of Sendai virus: sequence analysis of an epitope involved in fusion and virus neutralization. Virology 157:556–559
RichardsonC. D.,
ScheidA.,
ChoppinP. W.1980; Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at N-termini of the Fl or HA2 viral polypeptides. Virology 155:205–222
ScheidA.,
ChoppinP. W.1974; Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of inactive precursor protein of Sendai virus. Virology 57:475–490
ToyodaT.,
GotohB.,
SakaguchiT.,
KidaH.,
NagaiY.1988; Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. Journal of Virology 62:4427–4430
YusoffK.,
NesbitM.,
MccartneyH.,
EmmersonP. T.,
SamsonA. C. R.1988; Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus. Virus Research 11:319–333